Literature DB >> 12816899

Biological threat detection via host gene expression profiling.

Baochuan Lin1, Maryanne T Vahey, Dzung Thach, David A Stenger, Joseph J Pancrazio.   

Abstract

With the increased threat posed by biological weapons, detection techniques for biothreat pathogens are critically needed to monitor and assess the severity of the illness once exposure has occurred. Current approaches for detecting biological threats are either time-consuming or highly specific but provide little information regarding pathogenicity. Genotyping of pathogens by PCR provides a fast and definitive means for identifying pathogens, but reliance on pathogen genotypic endpoints has several limitations. Current progress in DNA microarrays technology provides an alternative way to address the issues faced by traditional detection systems through host gene expression profiles of peripheral blood cells. We discuss the advantages and critical issues facing the use of host gene expression profiling for biological threat detection.

Mesh:

Substances:

Year:  2003        PMID: 12816899     DOI: 10.1373/49.7.1045

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

Review 1.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Automated identification of multiple micro-organisms from resequencing DNA microarrays.

Authors:  Anthony P Malanoski; Baochuan Lin; Zheng Wang; Joel M Schnur; David A Stenger
Journal:  Nucleic Acids Res       Date:  2006-09-29       Impact factor: 16.971

3.  Gene expression signatures of radiation response are specific, durable and accurate in mice and humans.

Authors:  Sarah K Meadows; Holly K Dressman; Garrett G Muramoto; Heather Himburg; Alice Salter; ZhengZheng Wei; Geoffrey S Ginsburg; Geoff Ginsburg; Nelson J Chao; Joseph R Nevins; John P Chute
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.